این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
Cell Journal، جلد ۲۵، شماره ۹، صفحات ۶۳۳-۶۴۴
عنوان فارسی
چکیده فارسی مقاله
کلیدواژه‌های فارسی مقاله
عنوان انگلیسی Reversing T Cell Exhaustion by Converting Membrane PD-1 to Its Soluble form in Jurkat Cells; Applying The CRISPR/Cas9 Exon Skipping Strategy
چکیده انگلیسی مقاله Objective: T-cells express two functional forms of the programmed cell death protein 1 (PD-1): membrane (mPD-1) and
soluble (sPD-1). The binding of mPD-1 and its ligand (PD-L1) on tumor cells could lead activated lymphocytes toward
exhaustion. Selective deletion of the transmembrane domain via alternative splicing of exon-3 in PD-1 mRNA could
generate sPD-1. Overexpression of sPD-1 could disrupt the mPD-1/PD-L1 interaction in tumor-specific T cells. We
investigated the effect of secreted sPD-1 from pooled engineered and non-engineered T cell supernatant on survival
and proliferation of lymphocytes in the tumor microenvironment (TME).
Materials and Methods: In this experimental study, we designed two sgRNA sequences upstream and downstream of
exon-3 in the PDCD1 gene. The lentiCRISPRv2 puro vector was used to clone the dual sgRNAs and produce lentiviral
particles to transduce Jurkat T cells. Analysis assays were used to clarify the change in PD-1 expression pattern in the
pooled (engineered and non-engineered) Jurkat cells. Co-culture conditions were established with PD-L1+ cancer cells
and lymphocytes.
Results: CRISPR/Cas9 could delete exon-3 of the PDCD1 gene in the engineered cells based on the tracking of indels
by decomposition (TIDE) and interference of CRISPR edit (ICE) sequencing analysis reports. Our results showed a
12% reduction in mPD-1 positive cell population after CRISPR manipulation and increment in sPD-1 concentration in
the supernatant. The increased sPD-1 confirmed its positive effect on proliferation of lymphocytes co-cultured with PDL1+
cancer cells. The survival percent of lymphocytes co-cultured with the pooled cells supernatant was 12.5% more
than the control.
Conclusion: The CRISPR/Cas9 exon skipping approach could be used in adoptive cell immunotherapies to change
PD-1 expression patterns and overcome exhaustion.
کلیدواژه‌های انگلیسی مقاله CRISPR-Cas Systems, Exhaustion, Exons, PD-1-PD-L1 Blockade, Programmed Cell Death 1 Receptor
نویسندگان مقاله Zeinab Yousefi-Najafabadi |
Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran

Zohreh Mehmandoostli |
Immunology, Asthma and Allergy Research Institute (IAARI), Tehran University of Medical Sciences, Tehran, Iran

Yazdan Asgari |
Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran

Saeed Kaboli |
Department of Medical Biotechnology, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran

Reza Falak |
Department of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran

Gholam Ali Kardar |
Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran

نشانی اینترنتی https://www.celljournal.org/article_705477_e7bc442402e593b16d83783f0b5931bf.pdf
فایل مقاله فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده en
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده
برگشت به: صفحه اول پایگاه   |   نسخه مرتبط   |   نشریه مرتبط   |   فهرست نشریات